Bishal Gyawali/scri.queensu.ca
Mar 10, 2025, 08:32
Bishal Gyawali: Surrogate endpoints in cancer drug trials
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, shared a post on X:
“It’s Friday! That means it’s time to learn watching videos!
My new Medscape Skills Lab Video is out.
This time I talk about surrogate endpoints in cancer drug trials.
Don’t miss the whole series. Start from the beginning. I walk you through how I read a clinical trial publication.
Here is the link for the video.
Here’s a link to the whole series. Start from the oldest to the newest. We are approaching critical appraisal systematically. Starting from reading abstract, intro, to Methods. Currently we are at the primary endpoint.”
More posts featuring Bishal Gyawali.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 22:38
May 29, 2025, 22:26